טוען...
Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL
Clinical heterogeneity is a major barrier to effective treatment of chronic lymphocytic leukemia (CLL). Emerging evidence suggests that constitutive activation of various signaling pathways like mitogen-activated protein kinase–extracellular signal-regulated kinase (MAPK-Erk) signaling plays a role...
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4865588/ https://ncbi.nlm.nih.gov/pubmed/26809508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-09-669317 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|